Data are available upon request from Ms. Catherine Hamill (<hamillc@who.int>).

Introduction {#sec007}
============

Global mortality for infants under age 5 y halved from 90 to 43 deaths per 1,000 live births between 1990 and 2015. This is the result of a tremendous global effort to achieve the UN Millennium Development Goals \[[@pmed.1002220.ref001]\] and the goals of the UN Secretary-General's Every Woman Every Child initiative \[[@pmed.1002220.ref002]\]. Neonatal mortality in the first 28 d declined (by 47%) from 5.0 to 2.6 million deaths annually over this period. Unfortunately, inequality between countries persists, with 98% of neonatal deaths occurring in low- and middle-income countries \[[@pmed.1002220.ref003]\]. Importantly, more than 60% of such deaths are associated with low birthweight due to intrauterine growth restriction or preterm birth or both \[[@pmed.1002220.ref004],[@pmed.1002220.ref005]\]. Ultrasound imaging has become an essential tool for assuring correct gestational age and for fetal size assessment, increasingly so even in societies with restricted resources. Correspondingly, evidence is emerging at the population level that use of ultrasound biometry increases the rate of detection of fetal growth restriction and the identification of those at increased risk of neonatal morbidity \[[@pmed.1002220.ref006]\].

Birthweight, closely linked to fetal growth, is also a marker of risks for noncommunicable diseases in adult life, with cardiovascular diseases, type II diabetes, and obesity being the most prominent \[[@pmed.1002220.ref007],[@pmed.1002220.ref008]\]. While the birthweight gradient across the entire population reflects the distribution of degrees of such risk, it is increasingly evident that it is the developing physiology associated with fetal growth, rather than birthweight per se, that conditions cardiovascular, metabolic, endocrine, and neural functions for the life course, and thus long-term health and disease risks \[[@pmed.1002220.ref009]\]. For this reason, fetal growth data and aspects of intrauterine development need to be included as an important part of an early-life noncommunicable disease prevention initiative, as this targets the time when the effect of an intervention is greatest \[[@pmed.1002220.ref010]\].

A meeting of experts convened by WHO in 2002 reviewed current knowledge on birthweight as a health outcome and identified a need for research to develop fetal growth charts for international use \[[@pmed.1002220.ref011]\]. In 2006, WHO published the multicenter WHO Child Growth Standards \[[@pmed.1002220.ref012]\] using a prescriptive concept that assumes that, under optimal socioeconomic and nutritional conditions, all children follow one growth standard, regardless of ethnic background. Some support for this concept was drawn from previous studies \[[@pmed.1002220.ref013],[@pmed.1002220.ref014]\]. Although widely adopted, the applicability of these child growth standards has been questioned on the grounds of lack of fit to some populations \[[@pmed.1002220.ref015],[@pmed.1002220.ref016]\], especially for the head circumference standards \[[@pmed.1002220.ref017]\].

Recently, a large multicenter study, the Fetal Growth Longitudinal Study of the Intergrowth-21st Project \[[@pmed.1002220.ref018]\], applied the same concept and approach to fetal growth. The study presented growth standards using ultrasound biometric measurements but did not estimate fetal weight (EFW), even though this is the single most widely used clinical assessment of fetal growth today. Another large recent study, the NICHD Fetal Growth Studies, showed significant differences in fetal growth with ethnicity, and established ethnic-specific growth charts \[[@pmed.1002220.ref019]\]. This contradicts the prescriptive concept that one standard fits all. The study was, however, restricted to four self-reported ethnic groups of Asian, Hispanic, black, and white women in the US.

The present study is the fetal component of the WHO Multicentre Growth Reference Study, which aimed to establish growth charts for clinical use based on populations recruited from multiple countries \[[@pmed.1002220.ref020]\].

Methods {#sec008}
=======

Design {#sec009}
------

This was a multinational observational study approved by the WHO Research Project Review Panel (RP2) and the WHO Research Ethics Review Committee, secondarily approved by the national or local ethics review committee for each study center, and correspondingly carried out according to the Helsinki declaration on ethical principles for medical research in humans \[[@pmed.1002220.ref020],[@pmed.1002220.ref021]\]. All women were recruited specifically for this study, gave written informed consent at inclusion, and otherwise followed their conventional antenatal care program separately from study sessions. Study measurements were revealed to the clinician when the information was thought to be of importance for the management of the pregnancy. The study protocol was published previously \[[@pmed.1002220.ref020]\], so here we present a condensed account of the methods. The study selected participating centers from a range of ethnic and geographical settings, and intended to recruit 1,400 participants. The sample size calculation procedure was published previously \[[@pmed.1002220.ref020]\].

Setting {#sec010}
-------

The following centers participated in the study based on the proficient use of ultrasonography: Centro Rosarino de Estudios Perinatales, Rosario, Argentina; University of Campinas, Campinas, Brazil; University of Kinshasa, Kinshasa, Democratic Republic of the Congo (D. R. Congo); Rigshospitalet, Copenhagen University, Copenhagen, Denmark; Assiut University, Assiut, Egypt; Hôpital Antoine Béclère, Paris, France; University Medical Center, Hamburg-Eppendorf, Germany; All India Institute of Medical Sciences, New Delhi, India; Haukeland University Hospital, Bergen, Norway; and Khon Kaen University, Khon Kaen, Thailand.

Participants {#sec011}
------------

Participants without known health, environmental, and/or socioeconomic constraints were invited to participate in the study. Further inclusion criteria were used: living at an altitude lower than 1,500 m and near the study area (intended to promote compliance for the duration of the study and any possible follow-up studies); age ≥ 18 y and ≤ 40 y; body mass index (BMI) 18--30 kg/m^2^; singleton pregnancy; gestational age at entry between gestational week 8+0 d and 12+6 d according to reliable information on last menstrual period (LMP) and confirmed by ultrasound measurement of fetal crown--rump length; no history of chronic health problems; no long-term medication (including fertility treatment); no environmental or economic constraints likely to impede fetal growth; not smoking currently or in the previous 6 mo; no history of recurrent miscarriages; no previous preterm delivery (\<37 wk) or birthweight \< 2,500 g; and no evidence in the present pregnancy of congenital disease or fetal anomaly at study entry. Fetal anomalies detected during pregnancy or at birth were noted and verified postnatally. Pregnancies in which small-for-gestation-age fetuses were observed or intrauterine growth restriction was suspected were also noted. All mothers recruited were followed up until the end of the study, apart from those withdrawing consent.

Study Procedures {#sec012}
----------------

Women in the first trimester (before week 12+6 d of gestation) attending antenatal care clinics were approached by members of the study team and asked to participate. They were informed about the study objectives and procedures. Those who signed the consent form were enrolled in the study. After the ultrasound scan to assess agreement between gestational age based on LMP and that based on crown--rump length, they were scheduled for fetal biometry scans at monthly intervals.

All infants had an anthropometric assessment after delivery, including measurement of birthweight. All pregnant women in the study were asked for a 24-h dietary recall at entry into the study (and at 28 and 36 wk of gestation) \[[@pmed.1002220.ref022]\]. Clinically relevant conditions (e.g., hypertension, preeclampsia, and diabetes) occurring during pregnancy and childbirth were noted. Otherwise, no further procedures were added to the routine antenatal care provided at the study centers.

Gestational Age Assessment {#sec013}
--------------------------

Gestational age was confirmed by measuring the crown--rump length between gestational week 8 + 0 d and 12 + 6 d based on LMP and recorded as the average of three measurements. To acquire the crown--rump length, the midline sagittal section of the whole fetus was visualized with the fetus horizontal on the screen at 90 degrees to the angle of insonation. Gestational age was assessed by using the reference charts published by Robinson and Fleming \[[@pmed.1002220.ref023]\]. The woman was eligible for the study provided that gestational age by crown--rump length confirmed LMP-based age within 7 d. The LMP-based age was used for the analyses.

Ultrasound Measurements {#sec014}
-----------------------

The first visit (dating scan) was between 8 + 0 and 12 + 6 wk, and subsequent visits for fetal biometry were scheduled at approximately 4-wk (±1 wk) intervals at 14, 18, 24, 28, 32, 36, and 40 wk. All scanning appointments were arranged at the time of the dating scan and study enrollment. All participants were scanned in the lateral recumbent position.

The compulsory ultrasound measurements obtained at all visits included the following biometric parameters: biparietal diameter (BPD), head circumference (HC), abdominal circumference (AC), femur length (FL), and humerus length (HL). At each examination, all measurements were obtained three times from three separately generated ultrasound images and uploaded electronically (with the associated images) to the data management system. The median of the three measurements of each parameter was used in the analyses.

In addition, a full morphological evaluation (anomaly scan) was conducted at 18--24 wk following standard practice at each center. Fetuses diagnosed with any anomaly were managed according to local clinical guidelines. Their ultrasound measurements were included in the study, and the possible effect on the percentiles derived was evaluated. The following measurement techniques were used. BPD was measured as the outer--inner distance of the parietal bones in a cross-sectional view of the fetal head at the level of the thalami and cavum septi pellucidi or cerebral peduncles. The cerebellum was not included in the section. The measurement was obtained from an image with the midline echo as close as possible to the horizontal plane, 90 degrees to the ultrasound beam. HC was obtained from the same image as BPD as follows: calipers were placed on the outer borders of the occipital and frontal edges of the bone at the point of the midline of the skull, and the ellipse facility was used to follow the outer perimeter of the skull to calculate HC. AC was measured in the transverse section of the fetal abdomen that was as close as possible to circular and that included the stomach and the junction of the umbilical vein and portal sinus. The anteroposterior and transverse diameters were then measured with calipers placed on the outer borders of the body outline. The anteroposterior diameter was measured from the spine to the anterior abdominal wall, and the transverse diameter at a right angle to the anteroposterior diameter. The ellipse facility was used to calculate AC as outlined above. FL was measured from an image of the full femoral shaft in a plane close to 90 degrees to the ultrasound beam. The distal femoral epiphysis was excluded. Similarly, HL was measured from an image of the full humeral shaft in a plane close to 90 degrees to the ultrasound beam.

The participating centers used identical ultrasound machines during the project (Voluson Expert E8, General Electric, Kretz Ultrasound, Zipf, Austria) equipped with two curvilinear transabdominal transducers (4--8 MHz and 1--5 MHz) and a transvaginal transducer (6--12 MHz), observing that the energy output was set so that thermal index (TI) was \<1.0. The TI was automatically recorded and transmitted to the web-based data management system by the ultrasound machine.

Measurement results were stored electronically, with the images together with all information collected from the mother and the perinatal outcomes. EFW was calculated by including HC, AC, and FL in Hadlock et al.'s third formula \[[@pmed.1002220.ref024]\]. To facilitate assessment of relative fetal head size and growth, the ratios FL/HC and FL/BPD were established.

Training and Quality Assurance {#sec015}
------------------------------

The choice of participating centers was based on their proficient use of ultrasound by experienced sonographers. The sonographers participating in the study received specific training for the study and were certified as proficient under the supervision of a qualified instructor, according to a standard protocol. All the ultrasound operators had their scans assessed for quality during their early period in the project. Instruments and techniques used in all centers were standardized, i.e., equipment and training were provided to each of the measurement teams.

Maternal Anthropometric and Nutritional Assessment and Birthweight {#sec016}
------------------------------------------------------------------

Weight wearing light clothing was measured using a beam balance with nondetachable weights and recorded to the nearest 0.1 kg. Height of the mother was measured in the standing position using a stadiometer and recorded to the nearest millimeter. If the reading fell between two values, the lower was recorded.

The 24-h diet recall assessment was carried out by a specifically trained nutritionist or nurse who asked the study participant about food and beverages consumed during the previous 24 h \[[@pmed.1002220.ref022]\]. Further details are available elsewhere \[[@pmed.1002220.ref020]\]. Birthweight was assessed at delivery, and neonatal morphometry carried out within 24 h according to the protocol \[[@pmed.1002220.ref020]\].

Data Management {#sec017}
---------------

Data were collected via a web-based data management system developed by Centro Rosarino de Estudios Perinatales, Rosario, Argentina. All data (clinical, anthropometric, nutritional, and fetal biometry measurements plus 2-D/3-D images) were stored in a central server compliant with good clinical practice. Data transmission was encrypted to assure data integrity and patient confidentiality. Access to the web system was password protected, and only authorized users had access. Data changes were documented by a complete audit trail record kept automatically by the web system (recording when, by whom, and why data were changed). Data entered into the web system were checked by the coordinating unit at Centro Rosarino de Estudios Perinatales for completeness, accuracy, reliability, and consistent intended performance. Different kinds of validation procedures were carried out (checking missing values and outliers, cross-checks, cross-time verifications among scanning appointments, and protocol compliance). Measurements and 2-D/3-D images corresponding to fetal biometry had special processing. In collaboration with General Electric Healthcare, Germany, ViewPoint software was installed at all participating centers, allowing a standard interface/procedure for scans and an automatic transfer of fetal biometry measurements/images to the web-based system. Thus, all fetal biometry measurements considered by the protocol were automatically transferred instead of being entered manually (except for D. R. Congo; there, a complete checking of values was done by the comparison of images and values entered into the web-based system). The above mentioned web-based system and procedures have been used in five previous HRP (UNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction)/WHO multicenter studies and are proven to be efficient and compliant with HRP/WHO Standard Operating Procedures as well as with Title 21 CFR Part 11 of the Code of Federal Regulations, which deals with United States Food and Drug Administration guidelines on electronic records.

Adjustments of Analyses Compared with the Protocol and Justifications {#sec018}
---------------------------------------------------------------------

Compared with the original protocol \[[@pmed.1002220.ref020]\], the following aspects of the study were adjusted. Reliable information on LMP (confirmed by a measurement of crown--rump length), rather than ultrasound measured crown--rump length alone, was used as the basis for gestational age calculation for the following reasons: there is no evidence that ultrasound dating more accurately determines gestational age than a reliable LMP confirmed by crown--rump length; reliable LMP is the basis for establishing crown--rump length charts for dating; crown--rump length dating translates natural variation of size into variation of gestational age, which is not desirable for a study of growth; and LMP, not crown--rump length, is the accessible, low-cost method for gestational age assessment for all women in the world, and for the low-income areas usually the only one.

The sample size calculation was based on the assumption of normality for the distribution of ultrasound measurements. However, we used quantile regression, which calculates quantiles (i.e., percentiles) directly from the observed measurements without making assumptions about the distribution.

Maternal and fetal conditions occurring during pregnancy were not excluded from the analysis. The rationale for this was that the reference intervals of this study are intended primarily for clinical use and therefore should reflect the population for which they are intended as closely as possible. The pregnancy conditions (e.g., complications) that the study population experienced are those common to low-risk pregnancies around the world. Likewise, excluding all neonates below the 10th percentile of birthweight, as suggested in the protocol \[[@pmed.1002220.ref020]\], would by definition remove the 10% of the participants at the bottom of the range (the vast majority being healthy in this low-risk cohort) and cause a corresponding distortion of the new growth charts, i.e., a substantial upward shift of all the lowest percentiles (10, 5, 2.5, and 1) in the direction of supernormal.

Given the plethora of measurements, we prioritized clinical usefulness in the analyses and results presented here (e.g., EFW and common biometric measurements) and left the following for secondary studies and publications: transverse cerebellar diameter, fetal foot length, 3-D ultrasound acquisitions, maternal anthropometric measurements except height and weight, the second and third sets of dietary 24-h-recall data (at 28 and 36 wk of gestation), and newborn anthropometric measurements except birthweight.

Data Analysis and Statistical Methods {#sec019}
-------------------------------------

Descriptive statistics were calculated for the women's characteristics at study entry, for mode of delivery, for birth events, and for fetal, neonatal, and maternal conditions, by country and overall. Protocol compliance was evaluated by comparing the dates of the windows of gestational age defined in the protocol with the dates of actual measurements.

The ultrasound measurements were used to estimate reference curves for individual parameters (BPD, HC, AC, FL, HL, FL/HC, FL/BPD) and EFW based on Hadlock et al.'s formula 3 \[[@pmed.1002220.ref024]\]. Reference curves were fitted using quantile regression for reference models, as described by Wei et al. \[[@pmed.1002220.ref025]\] from the work of Koenker \[[@pmed.1002220.ref026],[@pmed.1002220.ref027]\].

The development of reference curves has up to now in general used parametric models, based on assumptions about distribution and on transformation of the observations to normal distributions. Advances brought by computer power and by the work of Koenker and others have made it possible to estimate the distributions directly by estimating their quantiles. Quantile regression is now a well-established technique \[[@pmed.1002220.ref026],[@pmed.1002220.ref027]\], and statistical software is available to fit quantile regression models. Quantile regression fits a function to each chosen quantile using linear programming and has the advantage of not imposing any distributional assumptions. The asymmetry and kurtosis of the fitted distributions may thus assume any form dictated by the data, even changing with gestational age. In addition, quantile regression is more robust against the influence of outliers in the data. The flexibility of the fitting and the fact that any inference drawn is entirely data-driven led us to choose quantile regression as the method for the construction of reference curves.

The estimated quantiles were smoothed by polynomial functions of gestational age. Full models fitted a polynomial on gestational age for each country by including interaction terms between gestational age polynomial and country. Additive terms were included for other covariates.

The models were checked by the residual analysis produced by the software. Hypotheses on the overall importance of covariates were formally tested using likelihood ratio or Wald chi-square tests. In addition, visual inspection of quantile profilers was used to assess the relevance of each covariate in explaining the variation. To compare the distributions of the different countries with the overall distribution, we used quantile--quantile plots. We calculated 95% confidence intervals for the difference between country and global EFW percentiles for particular gestational ages, using the result that the parameter estimates from quantile regression were asymptotically normally distributed \[[@pmed.1002220.ref028]\].

Logarithms of ultrasound parameters and EFW were used for the fitting. This was done only to achieve better numerical accuracy and faster convergence of the fitting algorithm. After the fitting, the results were retransformed to the original scale. To describe growth asymmetry, we used the Bowley coefficient of asymmetry \[[@pmed.1002220.ref029]\], based on differences of semi-quartile ranges relative to the quartile range, for the gestational ages 15 and 40 wk.

Data were analyzed using SAS Software version 9.4 (SAS Institute, Cary, North Carolina, US) and JMP Pro 12 (SAS Institute, Cary, North Carolina, US).

Results {#sec020}
=======

Participants {#sec021}
------------

A total of 1,439 women were enrolled between October 2009 and September 2014, with data collection being completed with the last childbirth in April 2015. Of these, 52 (3.6%) withdrew consent, leaving 1,387 women and their fetuses participating in the study. [Table 1](#pmed.1002220.t001){ref-type="table"} shows the numbers of women recruited, those withdrawing consent, those lost to follow-up, and those having miscarriages or intrauterine deaths, by country. Among women lost to follow-up and with miscarriage or intrauterine death, 10 and 15, respectively, did not contribute ultrasound information. All women other than those withdrawing consent were included in the growth curve analyses if they contributed ultrasound information, with the number in this analysis being 1,362.

10.1371/journal.pmed.1002220.t001

###### Number of women recruited to the study by country, with withdrawals and discontinuations.

![](pmed.1002220.t001){#pmed.1002220.t001g}

  Country       Number of Women Recruited   Consent Withdrawal   Discontinuation                               
  ------------- --------------------------- -------------------- ----------------- -------- --------- -------- ---------
  Argentina     143                         0                    0.0               2        1.4       1        0.7
  Brazil        157                         4                    2.5               2        1.3       3        1.9
  D. R. Congo   157                         15                   9.6               6        3.8       10       6.4
  Denmark       142                         2                    1.4               3        2.1       1        0.7
  Egypt         180                         25                   13.9              11       6.1       9        5.0
  France        109                         1                    0.9               9        8.3       2        1.8
  Germany       141                         0                    0.0               2        1.4       0        0.0
  India         146                         0                    0.0               7        4.8       3        2.1
  Norway        140                         2                    1.4               1        0.7       1        0.7
  Thailand      124                         3                    2.4               3        2.4       4        3.2
  **Total**     **1,439**                   **52**               **3.6**           **46**   **3.2**   **34**   **2.4**

\*Two medical abortions, 29 miscarriages, and three intrauterine deaths.

D. R. Congo, Democratic Republic of the Congo.

Population Characteristics {#sec022}
--------------------------

Statistics for participating women's characteristics, their daily caloric intake, and ethnicity are presented in [Table 2](#pmed.1002220.t002){ref-type="table"}. Median age at study entry was 28 y but varied between 24 y (Argentina and Egypt) and 32 y (France). Median maternal height ranged from 155 cm (India) to 169 cm (Germany), and weight from 54 kg (Thailand) to 66 kg (Germany). While overall median BMI was 23.1 kg/m^2^, the median by country ranged from 21.6 kg/m^2^ in Thailand to 25.9 kg/m^2^ in Egypt. Median daily caloric intake in the study group was 1,848 calories according to the 24-h dietary recall assessment, with Thailand having the lowest median, 1,232 calories, and Egypt having the highest median, 2,094 calories. The ethnic distribution of the study group was roughly 20% African (including the peri-Mediterranean Egypt), 20% Asian, and 60% white.

10.1371/journal.pmed.1002220.t002

###### Characteristics of the participating women by country at study entry.

![](pmed.1002220.t002){#pmed.1002220.t002g}

  Characteristic                              Statistic           Argentina (*N* = 143)   Brazil (*N* = 153)   D. R. Congo (*N* = 142)   Denmark (*N* = 140)   Egypt (*N* = 155)   France (*N* = 108)   Germany (*N* = 141)   India (*N* = 146)   Norway (*N* = 138)   Thailand (*N* = 121)   Total (*N* = 1,387)
  ------------------------------------------- ------------------- ----------------------- -------------------- ------------------------- --------------------- ------------------- -------------------- --------------------- ------------------- -------------------- ---------------------- ---------------------
  **Age (y)**                                 **Missing**         0                       0                    0                         0                     0                   0                    0                     0                   0                    0                      0
                                              **Q1**              20                      27                   24                        28                    22                  28                   28                    25                  26                   26                     25
                                              **Median**          24                      30                   27                        30                    24                  32                   31                    27                  28                   29                     28
                                              **Q3**              28                      33                   31                        32.5                  28                  34                   33                    30                  30                   32                     31
  **Weight (kg)**                             **Missing**         0                       0                    0                         1                     8                   0                    0                     0                   1                    1                      11
                                              **Q1**              52                      57                   53                        58                    57                  57                   60                    50                  59                   50                     55
                                              **Median**          58                      63                   60                        62                    65                  63                   66                    57                  63                   54                     61
                                              **Q3**              64                      69                   66                        67                    75                  69                   72                    62                  71                   59.5                   68
  **Height (cm)**                             **Missing**         0                       0                    0                         1                     8                   0                    0                     0                   1                    1                      11
                                              **Q1**              153                     160                  157                       164                   155                 162                  165                   152                 165                  155                    157
                                              **Median**          157                     163                  162                       168                   159                 165                  169                   155                 168                  157                    163
                                              **Q3**              162                     167                  165                       171                   163                 170                  174                   160                 173                  161                    168
  **BMI (kg/m**^**2**^**)**                   **Missing**         0                       0                    0                         1                     8                   0                    0                     0                   1                    1                      11
                                              **Q1**              21.2                    21.6                 20.8                      20.8                  23.5                21.1                 21.1                  20.0                20.5                 20.0                   21.0
                                              **Median**          23.3                    23.5                 22.9                      22.2                  25.9                22.9                 23.2                  23.0                22.2                 21.6                   23.1
                                              **Q3**              26.3                    25.8                 25.6                      24.1                  29.0                24.5                 24.9                  25.3                24.9                 23.9                   25.4
  **Total calories in 24-h dietary recall**   **Missing**         0                       0                    0                         0                     4                   10                   0                     28                  1                    6                      49
                                              **Q1**              1,666                   1,441                1,460                     1,584                 1,747               1,489                1,674                 1,514               1,558                1,004                  1,487
                                              **Median**          1,928                   1,709                2,063                     1,820                 2,094               1,736                1,978                 1,831               1,890                1,232                  1,848
                                              **Q3**              2,189                   2,148                2,605                     2,053                 2,525               2,053                2,285                 2,194               2,314                1,534                  2,222
  **Ethnicity, *n* (percent)**                **White**           143 (100.0)             146 (95.4)           0 (0.0)                   140 (100.0)           0 (0.0)             100 (92.6)           136 (96.5)            0 (0.0)             137 (99.3)           0 (0.0)                802 (57.8)
                                              **Asian**           0 (0.0)                 0 (0.0)              0 (0.0)                   0 (0.0)               0 (0.0)             0 (0.0)              2 (1.4)               146 (100.0)         1 (0.7)              121 (100.0)            270 (19.5)
                                              **African**         0 (0.0)                 7 (4.6)              142 (100.0)               0 (0.0)               133 (85.8)          8 (7.4)              3 (2.1)               0 (0.0)             0 (0.0)              0 (0.0)                293 (21.1)
                                              **Other**           0 (0.0)                 0 (0.0)              0 (0.0)                   0 (0.0)               22 (14.2)           0 (0.0)              0 (0.0)               0 (0.0)             0 (0.0)              0 (0.0)                22 (1.6)
  **Parity (nulliparous *n*)**                ***N***             137                     153                  142                       139                   57                  108                  141                   138                 138                  121                    1,274
                                              **Missing**         6                       0                    0                         1                     98                  0                    0                     8                   0                    0                      113
                                              ***n* (percent)**   64 (46.7)               108 (70.6)           51 (35.9)                 86 (61.9)             21 (36.8)           51 (47.2)            104 (73.8)            115 (83.3)          67 (48.6)            72 (59.5)              739 (58.0)

BMI, body mass index; D. R. Congo, Democratic Republic of the Congo; Q1, first quartile; Q3, third quartile.

Perinatal Outcomes {#sec023}
------------------

[Table 3](#pmed.1002220.t003){ref-type="table"} shows delivery information. The overall rate of spontaneous onset of birth was 67.3%, with a wide range by country: 28.5% in Brazil to 94.5% in D. R. Congo. There was an overall cesarean section rate of 32.1%, with a considerable range from 5.5% in D. R. Congo to 70.1% in Brazil. The occurrence of Apgar score \< 7 at 5 min was similar in all countries, i.e., 0%--2.2%. Most of the countries had a similar distribution between female and male neonates except for Egypt, Germany, and Norway, where about 40% of neonates were female. The incidence of preterm birth varied from 3.6% in Germany to 14.7% in Egypt (*p* = 0.03 for differences among countries). It was lowest in D. R. Congo, Denmark, Germany, and Norway and highest in Egypt and India.

10.1371/journal.pmed.1002220.t003

###### Mode of delivery, gestational age at birth and outcomes.

![](pmed.1002220.t003){#pmed.1002220.t003g}

  Characteristic                           Statistic            Argentina (*N* = 140)   Brazil (*N* = 150)   D. R. Congo (*N* = 127)   Denmark (*N* = 137)   Egypt (*N* = 140)   France (*N* = 97)   Germany (*N* = 139)   India (*N* = 139)   Norway (*N* = 136)   Thailand (*N* = 114)   All (*N* = 1,319)
  ---------------------------------------- -------------------- ----------------------- -------------------- ------------------------- --------------------- ------------------- ------------------- --------------------- ------------------- -------------------- ---------------------- -------------------
  **Neonatal sex (*n* female)**            ***N***              140                     148                  127                       136                   132                 97                  139                   137                 131                  112                    1,299
                                           ***n* (percent)**    68 (48.6)               70 (47.3)            67 (52.8)                 75 (55.1)             54 (40.9)           45 (46.4)           56 (40.3)             67 (48.9)           52 (39.7)            54 (48.2)              608 (46.8)
  **Apgar \< 7 at 5 min**                  ***N***              140                     147                  127                       135                   136                 97                  139                   138                 136                  113                    1,308
                                           ***n* (percent)**    1 (0.7)                 1 (0.7)              1 (0.8)                   1 (0.7)               3 (2.2)             0 (0.0)             1 (0.7)               1 (0.7)             2 (1.5)              0 (0.0)                11 (0.8)
  **Preterm (gestational age \< 37 wk)**   ***N***              140                     148                  127                       137                   136                 97                  139                   138                 136                  114                    1,312
                                           ***n* (percent)**    12 (8.6)                11 (7.4)             6 (4.7)                   8 (5.8)               20 (14.7)           7 (7.2)             5 (3.6)               15 (10.9)           6 (4.4)              9 (7.9)                99 (7.5)
  **Birthweight (g)**                      ***N***              140                     148                  127                       136                   117                 97                  139                   137                 136                  113                    1,290
  **Q1**                                   2,990                2,910                   2,850                3,133                     3,000                 2,965               3,100               2,656                 3,348               2,980                2,980                  
  **Median**                               3,328                3,290                   3,170                3,462                     3,100                 3,370               3,480               2,975                 3,575               3,130                3,300                  
  **Q3**                                   3,620                3,608                   3,500                3,790                     3,500                 3,600               3,820               3,200                 3,900               3,400                3,615                  
  **Gestational age (days)**               ***N***              140                     148                  127                       137                   139                 97                  139                   138                 136                  114                    1,315
                                           **Q1**               270                     268                  270                       272                   262                 273                 273                   265                 276                  267                    269
                                           **Median**           276                     273                  277                       282                   271                 279                 279                   270                 283                  271                    276
                                           **Q3**               281                     278                  283                       287                   280                 284                 285                   277                 288                  278                    282
  **Mode of delivery, *n* (percent)**      **Spontaneous**      91 (67.9)               41 (28.5)            120 (94.5)                105 (83.3)            64 (45.7)           80 (85.1)           82 (73.2)             84 (64.1)           113 (91.1)           58 (50.9)              838 (67.3)
                                           **Intrapartum CS**   30 (22.4)               33 (22.9)            6 (4.7)                   7 (5.6)               16 (11.4)           8 (8.5)             24 (21.4)             20 (15.3)           9 (7.3)              26 (22.8)              179 (14.4)
                                           **Elective CS**      13 (9.7)                68 (47.2)            1 (0.8)                   13 (10.3)             54 (38.6)           6 (6.4)             6 (5.4)               27 (20.6)           2 (1.6)              30 (26.3)              220 (17.7)
                                           **Vacuum**           0 (0.0)                 0 (0.0)              0 (0.0)                   11 (8.7)              0 (0.0)             0 (0.0)             25 (22.3)             5 (3.8)             1 (0.8)              0 (0.0)                42 (3.4)
                                           **Forceps**          6 (4.5)                 6 (4.2)              0 (0.0)                   0 (0.0)               0 (0.0)             3 (3.2)             2 (1.8)               3 (2.3)             11 (8.9)             0 (0.0)                31 (2.5)
                                           **Unknown**          0 (0.0)                 2 (1.4)              0 (0.0)                   1 (0.8)               6 (4.3)             0 (0.0)             0 (0.0)               0 (0.0)             0 (0.0)              0 (0.0)                9 (0.7)

CS, cesarean section; D. R. Congo, Democratic Republic of the Congo; Q1, first quartile; Q3, third quartile.

Gestational Age at Birth and Birthweight {#sec024}
----------------------------------------

Gestational age at birth varied between countries from a median of 38 wk 4 d in India to 40 wk 3 d in Norway (*p \<* 0.001 for differences among countries) ([Table 3](#pmed.1002220.t003){ref-type="table"}). Norway had the highest median birthweight (3,575 g), and Denmark and Germany had birthweights approximately 100 g less, while Argentina, Brazil, and France had birthweights 200 g less. There is a group of countries (D. R. Congo, Egypt, and Thailand) with birthweight a median 400 g less than that of Norway, and lastly India, with birthweight 500 g less. The differences in birthweight between countries were highly significant for all percentiles (*p \<* 0.001 for all). When adjusted for gestational age at birth, the differences were still significant for all the percentiles (*p* = 0.0018 for the 5th percentile and *p \<* 0.001 for the 10th, 25th, 50th, 75th, 90th, and 95th percentiles). The estimated birthweight according to neonatal sex and gestational age is shown in [Table 4](#pmed.1002220.t004){ref-type="table"}.

10.1371/journal.pmed.1002220.t004

###### Estimated birthweight percentiles for female and male neonates according to completed gestational week.

![](pmed.1002220.t004){#pmed.1002220.t004g}

  Percentile   Birthweight (g) by Gestational Age (wk)                                                                                   
  ------------ ----------------------------------------- ------- ------- ------- ------- ------- ------- ------- ------- ------- ------- -------
  **5**        1,968                                     2,315   2,575   2,748   2,835   2,834   2,062   2,451   2,723   2,880   2,921   2,845
  **25**       2,493                                     2,698   2,891   3,072   3,241   3,398   2,705   2,890   3,061   3,218   3,362   3,491
  **50**       2,786                                     2,990   3,173   3,336   3,479   3,601   2,919   3,153   3,354   3,519   3,650   3,747
  **75**       2,951                                     3,217   3,443   3,631   3,779   3,888   3,143   3,387   3,608   3,806   3,982   4,134
  **90**       3,181                                     3,451   3,682   3,871   4,021   4,130   3,450   3,666   3,871   4,067   4,253   4,428
  **95**       3,238                                     3,593   3,867   4,060   4,171   4,200   3,584   3,813   4,036   4,251   4,459   4,659

Maternal Complications and Perinatal Conditions {#sec025}
-----------------------------------------------

Conditions occurring in the mother during pregnancy are shown in [Table 5](#pmed.1002220.t005){ref-type="table"}, together with fetal malformations and neonatal conditions. In addition to globally experienced maternal complications such as preeclampsia, pregnancy-induced hypertension, gestational diabetes, and anemia, 42 had identified malaria. There was no maternal death. Four small-for-gestational-age fetuses were identified clinically, of which two were examined using Doppler ultrasound; none had abnormal recordings in the umbilical artery or middle cerebral artery, and all were kept in the analysis. It was registered when neonates needed transmission to the neonatal intensive care unit, commonly due to prematurity, respiratory distress syndrome, infections, or jaundice. There were three intrauterine deaths and three neonatal deaths, representing a perinatal mortality of 0.4%.

10.1371/journal.pmed.1002220.t005

###### Maternal complications, fetal malformations, and neonatal conditions by country.

![](pmed.1002220.t005){#pmed.1002220.t005g}

  Condition                                                          Argentina (*N* = 143)   Brazil (*N* = 153)   D. R. Congo (*N* = 142)   Denmark (*N* = 140)   Egypt (*N* = 155)   France (*N* = 108)   Germany (*N* = 141)   India (*N* = 146)   Norway (*N* = 138)   Thailand (*N* = 121)   All (*N* = 1,387)
  ------------------------------------------------------------------ ----------------------- -------------------- ------------------------- --------------------- ------------------- -------------------- --------------------- ------------------- -------------------- ---------------------- -------------------
  **Fetal malformation**[^**§**^](#t005fn002){ref-type="table-fn"}   4 (2.8)                 0 (0.0)              0 (0.0)                   0 (0.0)               1 (0.6)             1 (0.9)              1 (0.7)               0 (0.0)             1 (0.7)              0 (0.0)                8 (0.6)
  **Neonatal condition**                                             19 (13.3)               12 (7.8)             7 (4.9)                   10 (7.1)              4 (2.6)             2 (1.9)              9 (6.4)               8 (5.5)             3 (2.2)              9 (7.4)                83 (6.0)
  **Maternal complication**[\*](#t005fn003){ref-type="table-fn"}     24 (16.8)               10 (6.5)             42 (29.6)                 4 (2.9)               3 (1.9)             8 (7.4)              7 (5.0)               23 (15.8)           6 (4.3)              10 (8.3)               137 (9.9)

Data are given as *n* (percent).

^**§**^One malformation was discovered at birth, here counted as fetal malformation. Sacrococcygeal cyst (1), Jarcho-Levin syndrome (1), clubfoot (1), polycystic kidneys (1), cardiac malformations (3), cleft palate (1).

\*Preeclampsia (22), hypertension (16), gestational diabetes (32), malaria (42), anemia (19), and other (16); some participants had more than one diagnosis.

D. R. Congo, Democratic Republic of the Congo.

Compliance with Ultrasound Scans {#sec026}
--------------------------------

The median number of ultrasound scans (excluding the study entry screening scan) in all women was 6 (range 0--7). Compliance by gestational age window as defined in the protocol is presented in [S1 Table](#pmed.1002220.s008){ref-type="supplementary-material"}, by country and for all countries combined ("Total"). Compliance for all countries combined in each gestational age window was between 89.1% and 100%; 72% of the participants had a complete set of all the scheduled scans. In addition, for each of the measurements BPD, HC, AC, FL, and HL, scans were obtained ≥2 times for at least 95% of participants.

Thermal Index {#sec027}
-------------

Of the 8,372 scan sessions in the project, 115 had no scans stored and 54 belonged to women who withdrew consent, leaving 8,203 for the statistics. The median TI was 0.2, and none had TI ≥ 1.0.

Reference Intervals for Biometric Parameters and Estimated Fetal Weight {#sec028}
-----------------------------------------------------------------------

[Fig 1](#pmed.1002220.g001){ref-type="fig"} presents the overall growth curves for BPD, HC, AC, FL, HL, and EFW, and for the ratios FL/HC and FL/BPD, based on quantile regression. The corresponding reference values are shown in Tables [6](#pmed.1002220.t006){ref-type="table"}--[13](#pmed.1002220.t013){ref-type="table"} and in csv format in [S1 File](#pmed.1002220.s007){ref-type="supplementary-material"}.

![Percentiles for biparietal (outer--inner) diameter, head circumference, abdominal circumference, femur length, humerus length, estimated fetal weight, femur length/head circumference ratio, and femur length/biparietal diameter ratio during gestational weeks 14--40.\
The percentiles (percent) 1st, 5th, 10th, 50th, 90th, 95th, and 99th (smoothed lines) are based on quantile regression and are shown with the observed values (grey dots).](pmed.1002220.g001){#pmed.1002220.g001}

10.1371/journal.pmed.1002220.t006

###### Growth chart for fetal outer--inner biparietal diameter.

![](pmed.1002220.t006){#pmed.1002220.t006g}

  Gestational Age (Weeks)   Biparietal Diameter (mm) by Percentile                                        
  ------------------------- ---------------------------------------- ---- ---- ---- ---- ---- ----- ----- -----
  14                        23                                       24   24   26   27   28   29    30    31
  15                        26                                       27   27   29   30   31   32    33    34
  16                        29                                       30   30   32   33   35   36    37    38
  17                        32                                       33   33   35   36   38   39    40    41
  18                        35                                       36   37   38   40   41   43    44    45
  19                        38                                       39   40   42   43   45   46    47    48
  20                        41                                       42   43   45   47   48   50    51    52
  21                        44                                       45   46   48   50   52   53    54    55
  22                        47                                       48   50   51   53   55   57    58    59
  23                        50                                       52   53   55   57   59   60    61    62
  24                        53                                       55   56   58   60   62   64    65    66
  25                        56                                       58   59   61   63   65   67    68    69
  26                        59                                       60   62   64   66   68   70    71    72
  27                        62                                       63   65   67   69   71   73    74    75
  28                        64                                       66   67   69   72   74   76    77    78
  29                        67                                       68   70   72   74   76   78    80    81
  30                        69                                       71   72   74   77   79   81    82    83
  31                        71                                       73   74   76   79   81   83    85    86
  32                        73                                       75   76   79   81   83   86    87    88
  33                        75                                       77   78   81   83   86   88    89    90
  34                        77                                       79   80   83   85   88   90    91    92
  35                        79                                       80   82   84   87   89   92    93    94
  36                        80                                       82   84   86   89   91   93    95    96
  37                        82                                       84   85   88   90   93   95    96    97
  38                        84                                       85   87   90   92   95   97    98    99
  39                        85                                       87   89   92   94   96   99    100   101
  40                        87                                       88   90   93   96   98   100   101   102

10.1371/journal.pmed.1002220.t007

###### Growth chart for fetal head circumference.

![](pmed.1002220.t007){#pmed.1002220.t007g}

  Gestational Age (Weeks)   Head Circumference (mm) by Percentile                                             
  ------------------------- --------------------------------------- ----- ----- ----- ----- ----- ----- ----- -----
  14                        86                                      88    91    95    100   104   107   110   112
  15                        97                                      99    102   106   111   115   119   122   124
  16                        108                                     111   114   118   123   128   132   134   137
  17                        120                                     123   126   130   135   140   144   147   149
  18                        132                                     135   138   143   148   153   157   160   162
  19                        145                                     147   150   155   161   166   170   173   175
  20                        157                                     159   163   168   173   179   183   186   188
  21                        169                                     172   175   180   186   191   196   199   201
  22                        181                                     184   187   193   198   204   209   212   214
  23                        193                                     196   199   205   210   216   221   224   227
  24                        204                                     207   211   216   222   228   233   236   239
  25                        215                                     218   222   227   233   239   245   248   251
  26                        225                                     228   232   238   244   250   256   259   262
  27                        234                                     238   242   248   254   261   267   270   273
  28                        243                                     247   251   257   264   270   277   280   283
  29                        251                                     256   260   266   273   280   286   290   293
  30                        259                                     264   268   274   281   288   295   299   302
  31                        266                                     271   275   282   289   296   303   307   311
  32                        273                                     278   282   289   296   304   311   315   318
  33                        279                                     284   289   295   303   311   318   322   326
  34                        285                                     290   295   302   309   317   324   328   332
  35                        291                                     296   300   307   315   323   330   335   338
  36                        296                                     301   306   313   321   329   336   340   344
  37                        302                                     306   311   318   326   334   341   345   349
  38                        307                                     311   315   324   332   339   347   350   354
  39                        313                                     316   320   329   337   344   352   355   359
  40                        319                                     321   325   334   342   350   357   360   363

10.1371/journal.pmed.1002220.t008

###### Growth chart for fetal abdominal circumference.

![](pmed.1002220.t008){#pmed.1002220.t008g}

  Gestational Age (Weeks)   Abdominal Circumference (mm) by Percentile                                             
  ------------------------- -------------------------------------------- ----- ----- ----- ----- ----- ----- ----- -----
  14                        69                                           71    73    77    81    86    89    92    95
  15                        79                                           81    83    87    92    96    100   103   106
  16                        89                                           91    93    98    103   108   112   115   118
  17                        99                                           102   104   109   114   119   124   127   130
  18                        110                                          113   116   121   126   131   136   139   142
  19                        121                                          124   127   132   138   143   148   152   155
  20                        132                                          136   139   144   150   155   161   164   167
  21                        143                                          147   150   156   162   168   173   177   180
  22                        154                                          159   162   167   173   180   186   189   193
  23                        165                                          170   173   179   185   192   198   202   205
  24                        176                                          181   184   190   197   203   210   214   217
  25                        186                                          191   195   201   208   215   222   226   229
  26                        196                                          201   205   212   219   226   233   238   241
  27                        206                                          211   215   222   230   237   245   249   253
  28                        215                                          220   225   232   240   248   256   260   264
  29                        224                                          229   234   242   250   258   266   271   276
  30                        233                                          238   243   251   260   269   277   282   287
  31                        241                                          246   252   260   269   279   287   292   298
  32                        249                                          254   260   269   279   288   298   303   308
  33                        257                                          262   269   278   288   298   308   313   319
  34                        265                                          270   277   287   298   308   318   324   330
  35                        273                                          279   286   297   307   318   329   335   342
  36                        282                                          287   294   306   317   329   340   346   353
  37                        290                                          296   304   316   328   340   352   358   365
  38                        299                                          306   313   326   338   351   364   371   378
  39                        309                                          316   324   337   350   363   377   384   392
  40                        319                                          327   335   349   363   377   391   399   406

10.1371/journal.pmed.1002220.t009

###### Growth chart for fetal femur length.

![](pmed.1002220.t009){#pmed.1002220.t009g}

  Gestational Age (Weeks)   Femur Length (mm) by Percentile                                      
  ------------------------- --------------------------------- ---- ---- ---- ---- ---- ---- ---- ----
  14                        10                                10   11   12   13   14   15   16   17
  15                        12                                13   14   15   16   17   18   19   20
  16                        15                                16   17   18   19   20   22   22   23
  17                        19                                19   20   21   22   24   25   26   26
  18                        22                                22   23   24   26   27   28   29   30
  19                        25                                26   26   28   29   30   31   32   33
  20                        28                                29   30   31   32   33   35   35   36
  21                        31                                32   33   34   35   36   38   38   39
  22                        34                                35   35   37   38   39   40   41   42
  23                        36                                37   38   39   41   42   43   44   45
  24                        39                                40   41   42   43   45   46   47   47
  25                        41                                42   43   44   46   47   48   49   50
  26                        43                                44   45   46   48   49   51   51   52
  27                        46                                46   47   49   50   52   53   54   55
  28                        48                                48   49   51   52   54   55   56   57
  29                        50                                50   51   53   54   56   57   58   59
  30                        51                                52   53   55   56   58   60   60   61
  31                        53                                54   55   57   59   60   62   63   64
  32                        55                                56   57   59   61   62   64   65   66
  33                        57                                58   60   61   63   65   66   67   68
  34                        59                                60   61   63   65   67   68   69   70
  35                        61                                62   63   65   67   69   70   71   73
  36                        63                                64   65   67   69   70   72   73   75
  37                        65                                66   67   68   70   72   74   75   76
  38                        66                                67   68   70   72   74   75   77   78
  39                        67                                68   69   70   73   75   76   78   79
  40                        68                                68   69   70   73   75   77   78   79

10.1371/journal.pmed.1002220.t010

###### Growth chart for fetal humerus length.

![](pmed.1002220.t010){#pmed.1002220.t010g}

  Gestational Age (Weeks)   Humerus Length (mm) by Percentile                                      
  ------------------------- ----------------------------------- ---- ---- ---- ---- ---- ---- ---- ----
  14                        10                                  11   11   12   14   15   16   16   17
  15                        13                                  13   14   15   16   18   19   19   20
  16                        16                                  16   17   18   19   21   22   22   23
  17                        19                                  19   20   21   23   24   25   25   26
  18                        22                                  22   23   24   26   27   28   28   29
  19                        25                                  25   26   27   28   30   31   31   32
  20                        27                                  28   29   30   31   32   33   34   35
  21                        30                                  31   31   33   34   35   36   37   38
  22                        32                                  33   34   35   36   37   39   39   40
  23                        34                                  35   36   37   38   40   41   42   42
  24                        36                                  37   38   39   41   42   43   44   45
  25                        38                                  39   40   41   42   44   45   46   47
  26                        40                                  41   42   43   44   46   47   48   49
  27                        42                                  43   43   45   46   47   49   50   51
  28                        43                                  44   45   46   48   49   51   52   52
  29                        45                                  46   47   48   49   51   52   53   54
  30                        46                                  47   48   50   51   53   54   55   56
  31                        48                                  49   50   51   53   54   56   57   58
  32                        49                                  50   51   53   54   56   57   59   59
  33                        51                                  52   53   54   56   58   59   60   61
  34                        53                                  53   54   56   58   59   61   62   63
  35                        54                                  55   56   57   59   61   62   63   64
  36                        55                                  56   57   59   61   62   64   65   66
  37                        56                                  57   58   60   62   64   65   66   67
  38                        57                                  58   59   61   63   65   66   67   68
  39                        58                                  59   60   62   64   65   67   68   69
  40                        57                                  58   60   62   64   66   68   69   69

10.1371/journal.pmed.1002220.t011

###### Growth chart for estimated fetal weight regardless of fetal sex.

![](pmed.1002220.t011){#pmed.1002220.t011g}

  Gestational Age (Weeks)   Estimated Fetal Weight (g) by Percentile                                                           
  ------------------------- ------------------------------------------ ------- ------- ------- ------- ------- ------- ------- -------
  14                        70                                         73      78      83      90      98      104     109     113
  15                        89                                         93      99      106     114     124     132     138     144
  16                        113                                        117     124     133     144     155     166     174     181
  17                        141                                        146     155     166     179     193     207     217     225
  18                        174                                        181     192     206     222     239     255     268     278
  19                        214                                        223     235     252     272     292     313     328     340
  20                        260                                        271     286     307     330     355     380     399     413
  21                        314                                        327     345     370     398     428     458     481     497
  22                        375                                        392     412     443     476     512     548     575     595
  23                        445                                        465     489     525     565     608     650     682     705
  24                        523                                        548     576     618     665     715     765     803     830
  25                        611                                        641     673     723     778     836     894     938     970
  26                        707                                        743     780     838     902     971     1,038   1,087   1,125
  27                        813                                        855     898     964     1,039   1,118   1,196   1,251   1,295
  28                        929                                        977     1,026   1,102   1,189   1,279   1,368   1,429   1,481
  29                        1,053                                      1,108   1,165   1,251   1,350   1,453   1,554   1,622   1,682
  30                        1,185                                      1,247   1,313   1,410   1,523   1,640   1,753   1,828   1,897
  31                        1,326                                      1,394   1,470   1,579   1,707   1,838   1,964   2,046   2,126
  32                        1,473                                      1,548   1,635   1,757   1,901   2,047   2,187   2,276   2,367
  33                        1,626                                      1,708   1,807   1,942   2,103   2,266   2,419   2,516   2,619
  34                        1,785                                      1,872   1,985   2,134   2,312   2,492   2,659   2,764   2,880
  35                        1,948                                      2,038   2,167   2,330   2,527   2,723   2,904   3,018   3,148
  36                        2,113                                      2,205   2,352   2,531   2,745   2,959   3,153   3,277   3,422
  37                        2,280                                      2,372   2,537   2,733   2,966   3,195   3,403   3,538   3,697
  38                        2,446                                      2,536   2,723   2,935   3,186   3,432   3,652   3,799   3,973
  39                        2,612                                      2,696   2,905   3,135   3,403   3,664   3,897   4,058   4,247
  40                        2,775                                      2,849   3,084   3,333   3,617   3,892   4,135   4,312   4,515

10.1371/journal.pmed.1002220.t012

###### Growth chart for fetal femur length/head circumference ratio.

![](pmed.1002220.t012){#pmed.1002220.t012g}

  Gestational Age (Weeks)   Femur Length/Head Circumference Ratio by Percentile                                                    
  ------------------------- ----------------------------------------------------- ------ ------ ------ ------ ------ ------ ------ ------
  14                        0.50                                                  0.52   0.53   0.54   0.56   0.57   0.59   0.59   0.60
  15                        0.54                                                  0.55   0.56   0.57   0.59   0.60   0.61   0.62   0.62
  16                        0.57                                                  0.58   0.59   0.60   0.61   0.62   0.63   0.64   0.64
  17                        0.60                                                  0.60   0.61   0.62   0.63   0.64   0.65   0.65   0.66
  18                        0.62                                                  0.62   0.63   0.64   0.65   0.66   0.66   0.67   0.67
  19                        0.64                                                  0.64   0.65   0.65   0.66   0.67   0.68   0.68   0.68
  20                        0.65                                                  0.66   0.66   0.67   0.67   0.68   0.69   0.69   0.69
  21                        0.66                                                  0.67   0.67   0.68   0.68   0.69   0.69   0.70   0.70
  22                        0.67                                                  0.67   0.68   0.68   0.69   0.69   0.70   0.70   0.71
  23                        0.68                                                  0.68   0.68   0.69   0.69   0.70   0.70   0.71   0.71
  24                        0.68                                                  0.69   0.69   0.69   0.70   0.70   0.71   0.71   0.71
  25                        0.69                                                  0.69   0.69   0.70   0.70   0.71   0.71   0.71   0.72
  26                        0.69                                                  0.69   0.69   0.70   0.70   0.71   0.71   0.72   0.72
  27                        0.69                                                  0.69   0.70   0.70   0.71   0.71   0.72   0.72   0.72
  28                        0.69                                                  0.70   0.70   0.70   0.71   0.71   0.72   0.72   0.72
  29                        0.70                                                  0.70   0.70   0.71   0.71   0.72   0.72   0.72   0.73
  30                        0.70                                                  0.70   0.70   0.71   0.71   0.72   0.72   0.73   0.73
  31                        0.70                                                  0.70   0.71   0.71   0.72   0.72   0.73   0.73   0.73
  32                        0.70                                                  0.71   0.71   0.72   0.72   0.73   0.73   0.73   0.74
  33                        0.71                                                  0.71   0.71   0.72   0.72   0.73   0.73   0.74   0.74
  34                        0.71                                                  0.71   0.72   0.72   0.73   0.73   0.74   0.74   0.74
  35                        0.71                                                  0.72   0.72   0.73   0.73   0.74   0.74   0.74   0.75
  36                        0.72                                                  0.72   0.72   0.73   0.73   0.74   0.74   0.75   0.75
  37                        0.72                                                  0.72   0.73   0.73   0.74   0.74   0.74   0.75   0.75
  38                        0.72                                                  0.72   0.73   0.73   0.74   0.74   0.75   0.75   0.75
  39                        0.72                                                  0.72   0.73   0.73   0.74   0.74   0.75   0.75   0.75
  40                        0.71                                                  0.72   0.72   0.73   0.73   0.74   0.75   0.75   0.75

10.1371/journal.pmed.1002220.t013

###### Growth chart for fetal femur length/biparietal diameter.

![](pmed.1002220.t013){#pmed.1002220.t013g}

  Gestational Age (Weeks)   Femur Length/Biparietal Diameter Ratio by Percentile                                                    
  ------------------------- ------------------------------------------------------ ------ ------ ------ ------ ------ ------ ------ ------
  14                        0.71                                                   0.72   0.74   0.76   0.78   0.80   0.82   0.83   0.84
  15                        0.75                                                   0.76   0.77   0.79   0.81   0.83   0.84   0.85   0.86
  16                        0.79                                                   0.80   0.81   0.82   0.84   0.85   0.87   0.88   0.88
  17                        0.82                                                   0.82   0.83   0.85   0.86   0.87   0.89   0.89   0.90
  18                        0.84                                                   0.85   0.85   0.87   0.88   0.89   0.90   0.91   0.91
  19                        0.86                                                   0.86   0.87   0.88   0.89   0.90   0.91   0.92   0.92
  20                        0.87                                                   0.88   0.88   0.89   0.90   0.91   0.92   0.93   0.93
  21                        0.88                                                   0.89   0.89   0.90   0.91   0.92   0.93   0.93   0.94
  22                        0.89                                                   0.89   0.90   0.91   0.92   0.92   0.93   0.94   0.94
  23                        0.89                                                   0.90   0.90   0.91   0.92   0.93   0.94   0.94   0.95
  24                        0.90                                                   0.90   0.91   0.91   0.92   0.93   0.94   0.94   0.95
  25                        0.90                                                   0.90   0.91   0.92   0.92   0.93   0.94   0.94   0.95
  26                        0.90                                                   0.91   0.91   0.92   0.93   0.93   0.94   0.95   0.95
  27                        0.90                                                   0.91   0.91   0.92   0.93   0.93   0.94   0.95   0.95
  28                        0.90                                                   0.91   0.91   0.92   0.93   0.94   0.94   0.95   0.95
  29                        0.90                                                   0.91   0.91   0.92   0.93   0.94   0.94   0.95   0.95
  30                        0.91                                                   0.91   0.91   0.92   0.93   0.94   0.94   0.95   0.95
  31                        0.91                                                   0.91   0.92   0.92   0.93   0.94   0.95   0.95   0.95
  32                        0.91                                                   0.91   0.92   0.93   0.93   0.94   0.95   0.95   0.96
  33                        0.91                                                   0.92   0.92   0.93   0.94   0.94   0.95   0.96   0.96
  34                        0.92                                                   0.92   0.92   0.93   0.94   0.95   0.95   0.96   0.96
  35                        0.92                                                   0.92   0.93   0.93   0.94   0.95   0.95   0.96   0.96
  36                        0.92                                                   0.93   0.93   0.94   0.94   0.95   0.96   0.96   0.97
  37                        0.92                                                   0.93   0.93   0.94   0.94   0.95   0.96   0.96   0.97
  38                        0.92                                                   0.93   0.93   0.94   0.95   0.95   0.96   0.96   0.97
  39                        0.92                                                   0.92   0.93   0.94   0.94   0.95   0.96   0.96   0.97
  40                        0.91                                                   0.92   0.92   0.93   0.94   0.95   0.96   0.96   0.97

The distribution of EFW starts with a slight asymmetry to the left (i.e., lower percentiles) in early pregnancy and ends with a very noticeable right asymmetry (i.e., higher percentiles) in later pregnancy. The Bowley coefficient of asymmetry \[[@pmed.1002220.ref029]\], based on differences of semi-quartile ranges relative to the quartile range, was −0.016 for gestational age 15 wk and +0.111 for 40 wk.

Influence of Covariates on Growth Percentiles {#sec029}
---------------------------------------------

### Fetal sex {#sec030}

Male fetuses were larger than female fetuses as measured by EFW, but the disparity was smaller in the lower quantiles of the distribution (3.5%) and larger in the upper quantiles (4.5%) (Fig [2](#pmed.1002220.g002){ref-type="fig"} and [S2 Table](#pmed.1002220.s009){ref-type="supplementary-material"}, without adjustment for country differences). This difference in size by fetal sex was significant at the 5% level for all percentiles. EFW reference values were also established for female and male fetuses separately (Tables [14](#pmed.1002220.t014){ref-type="table"} and [15](#pmed.1002220.t015){ref-type="table"}) to allow assessment customized according to fetal sex. For example, at gestational week 37, the median EFW of female fetuses is 84 g lower than that of male fetuses.

![Female and male growth of estimated fetal weight during gestational weeks 14--40.\
The difference in growth for female (F; red) and male (M; blue) fetuses is shown by the 5th, 50th, and 95th percentiles for EFW growth. The smoothed lines are based on quantile regression that includes data from all the participating countries.](pmed.1002220.g002){#pmed.1002220.g002}

10.1371/journal.pmed.1002220.t014

###### Growth chart for estimated fetal weight for female fetuses.

![](pmed.1002220.t014){#pmed.1002220.t014g}

  Gestational Age (Weeks)   Female Estimated Fetal Weight (g) by Percentile                                           
  ------------------------- ------------------------------------------------- ------- ------- ------- ------- ------- -------
  14                        73                                                77      82      89      96      102     107
  15                        92                                                97      104     113     121     129     135
  16                        116                                               122     131     141     152     162     170
  17                        145                                               152     164     176     189     202     211
  18                        180                                               188     202     217     233     248     261
  19                        221                                               231     248     266     285     304     319
  20                        269                                               281     302     322     346     369     387
  21                        324                                               339     364     388     417     444     466
  22                        388                                               405     435     464     499     530     557
  23                        461                                               481     516     551     592     629     660
  24                        542                                               567     608     649     697     740     776
  25                        634                                               663     710     758     815     865     907
  26                        735                                               769     823     880     946     1,003   1,051
  27                        846                                               886     948     1,014   1,090   1,156   1,210
  28                        967                                               1,013   1,083   1,160   1,247   1,323   1,383
  29                        1,096                                             1,150   1,230   1,319   1,418   1,505   1,570
  30                        1,234                                             1,296   1,386   1,489   1,601   1,699   1,770
  31                        1,379                                             1,451   1,553   1,670   1,796   1,907   1,984
  32                        1,530                                             1,614   1,728   1,861   2,002   2,127   2,209
  33                        1,687                                             1,783   1,911   2,060   2,217   2,358   2,445
  34                        1,847                                             1,957   2,101   2,268   2,440   2,598   2,690
  35                        2,008                                             2,135   2,296   2,481   2,669   2,846   2,943
  36                        2,169                                             2,314   2,494   2,698   2,902   3,099   3,201
  37                        2,329                                             2,493   2,695   2,917   3,138   3,357   3,462
  38                        2,484                                             2,670   2,896   3,136   3,373   3,616   3,725
  39                        2,633                                             2,843   3,096   3,354   3,605   3,875   3,988
  40                        2,775                                             3,010   3,294   3,567   3,832   4,131   4,247

10.1371/journal.pmed.1002220.t015

###### Growth chart for estimated fetal weight (EFW) for male fetuses.

![](pmed.1002220.t015){#pmed.1002220.t015g}

  Gestational Age (Weeks)   Male Estimated Fetal Weight (g) by Percentile                                           
  ------------------------- ----------------------------------------------- ------- ------- ------- ------- ------- -------
  14                        75                                              79      84      92      99      105     109
  15                        96                                              100     107     116     126     134     139
  16                        121                                             127     136     146     158     169     175
  17                        152                                             158     170     183     197     210     219
  18                        188                                             196     210     226     243     260     271
  19                        232                                             241     258     277     298     320     333
  20                        282                                             293     314     337     362     389     405
  21                        341                                             354     380     407     436     469     489
  22                        408                                             424     454     487     522     561     586
  23                        484                                             503     539     578     619     666     695
  24                        570                                             592     635     681     730     785     818
  25                        666                                             692     742     795     853     917     956
  26                        772                                             803     860     923     990     1,063   1,109
  27                        888                                             924     989     1,063   1,141   1,224   1,276
  28                        1,014                                           1,055   1,129   1,215   1,305   1,399   1,458
  29                        1,149                                           1,197   1,281   1,379   1,482   1,587   1,654
  30                        1,293                                           1,349   1,442   1,555   1,672   1,788   1,863
  31                        1,445                                           1,509   1,613   1,741   1,874   2,000   2,085
  32                        1,605                                           1,677   1,793   1,937   2,085   2,224   2,319
  33                        1,770                                           1,852   1,980   2,140   2,306   2,456   2,562
  34                        1,941                                           2,032   2,174   2,350   2,534   2,694   2,814
  35                        2,114                                           2,217   2,372   2,565   2,767   2,938   3,072
  36                        2,290                                           2,404   2,574   2,783   3,002   3,185   3,334
  37                        2,466                                           2,591   2,777   3,001   3,238   3,432   3,598
  38                        2,641                                           2,778   2,981   3,218   3,472   3,676   3,863
  39                        2,813                                           2,962   3,183   3,432   3,701   3,916   4,125
  40                        2,981                                           3,142   3,382   3,639   3,923   4,149   4,383

### Country {#sec031}

Countries differed in EFW ([Fig 3](#pmed.1002220.g003){ref-type="fig"}). Using country as a covariate in a quantile regression model, including interaction terms with gestational age, showed significance at the 5% level for all percentiles 5th, 10th, 25th, 50th, 75th, 90th, and 95th ([S2](#pmed.1002220.s009){ref-type="supplementary-material"} and [S3](#pmed.1002220.s010){ref-type="supplementary-material"} Tables). This variation due to country was adjusted for maternal characteristics (mother's age, parity, height, and weight, or with BMI substituting the latter two) and sex of the fetus. To assess the relative contribution of these variables to the variation in EFW, the Wald chi-square statistics in [S2](#pmed.1002220.s009){ref-type="supplementary-material"} and [S3](#pmed.1002220.s010){ref-type="supplementary-material"} Tables are informative, e.g., for the 5th percentile (quantile 0.05, first table in [S2 Table](#pmed.1002220.s009){ref-type="supplementary-material"}), as expected, most of the variation (Wald chi-square = 1,797, 1 df) is due to gestational age (linear) as the fetus grows, and there is significant curvature (Wald chi-square = 207, 1 df). Country variation gives Wald chi-square = 36 (9 df); sex of the fetus, 29 (1 df); mother's height, 26 (1 df); and mother's age, 22 (1 df), while the Wald chi-square value for weight is negligible. In the same table, the level of significance is listed for these variables, e.g., *p* \< 0.001 for country, highly significant. It is clear that variation due to country also occurs independently of maternal characteristics and the sex of the fetus. [Fig 3](#pmed.1002220.g003){ref-type="fig"} offers a visualization of country variation for the 10th, 50th, and 90th percentiles for EFW. Country variation in the other ultrasound parameters for the 10th, 50th, and 90th percentiles is presented in [S2](#pmed.1002220.s002){ref-type="supplementary-material"}--[S6](#pmed.1002220.s006){ref-type="supplementary-material"} Figs. Country differences in EFW percentiles and overall EFW percentiles are presented in [S4 Table](#pmed.1002220.s011){ref-type="supplementary-material"}.

![Influence of country on estimated fetal weight.\
The 10th, 50th, and 90th percentiles for estimated fetal weight in grams for the ten participating countries, with variation due to country becoming more obvious towards the end of gestation. Congo, Democratic Republic of the Congo.](pmed.1002220.g003){#pmed.1002220.g003}

The clinical relevance of the differences between the country quantiles and the global quantiles can be assessed in quantile--quantile plots ([Fig 4](#pmed.1002220.g004){ref-type="fig"}). These plots are intended to enable the reader to derive the magnitude of difference in grams for any size and country and percentile. For example, consider the quantile--quantile plot for the individual country 0.05 quantile (i.e., the 5th percentile) for EFW versus the global 0.05 quantile: the 5th percentiles at low values of EFW cannot be differentiated because of the relative smallness of EFW at early pregnancy ([Fig 4](#pmed.1002220.g004){ref-type="fig"}). However, at the end of gestation (high values of EFW), the 5th percentile for Norway is 3,200 g, while the overall 5th percentile is 2,800 g; for France it is 2,800 g, and for Egypt, 2,700 g. Similarly, it can be seen that while the 10th percentile for EFW at the end of gestation for Norway is 3,400 g, it is 2,700 g for India (versus about 3,100 g for the global 10th percentile), showing that a fetus weighing 3,200 g would be below the 10th percentile for Norway but well above it for India. The magnitude of the differences among countries can also be appreciated in [Fig 5](#pmed.1002220.g005){ref-type="fig"}, where selected country percentiles are shown with the corresponding global percentile curve.

![Quantile--quantile plots comparing countries' distributions with the global distribution of estimated fetal weight.\
The 5th, 10th, 25th, 50th, 75th, 90th, and 95th percentiles (Q05, Q10, Q25, Q50, Q75, and Q90, respectively) for the distribution of each country are plotted versus the same percentiles of the global distribution (global Q05, global Q10, global Q25, global Q50, global Q75, global Q90, respectively). Congo, Democratic Republic of the Congo.](pmed.1002220.g004){#pmed.1002220.g004}

![Country differences in estimated fetal weight.\
Selected percentiles for estimated fetal weight (EFW) for the ten participating countries, showing the magnitude of differences (red, 5th percentile; blue, 50th percentile; green, 95th percentile; each dot denotes a country).](pmed.1002220.g005){#pmed.1002220.g005}

### Maternal age and maternal height {#sec032}

Maternal age and height seem to be associated with a positive effect on EFW, especially in the lower tail of the distribution, significant at the 5% level, of the order of 2% to 3% for each additional 10 y of age of the mother and 1% to 2% for each additional 10 cm of height ([S1D and S1F Fig](#pmed.1002220.s001){ref-type="supplementary-material"}, without adjusting for country differences).

### Maternal weight {#sec033}

Maternal weight seems to be associated with a small positive effect on EFW, especially in the higher tail of the distribution, significant at the 5% level, of the order of 1% to 1.5% for each additional 10 kg of weight of the mother ([S1E Fig](#pmed.1002220.s001){ref-type="supplementary-material"}, without adjusting for country differences).

### Parity (0 versus ≥1) {#sec034}

Parous women had heavier fetuses than nulliparous women, with the disparity being much higher in the lower quantiles of the distribution, of the order of 1% to 3%, significant at the 5% level, and subsiding in the upper quantiles ([S1C Fig](#pmed.1002220.s001){ref-type="supplementary-material"}, without adjusting for country differences).

Influence of Clinical Conditions on Growth Percentiles {#sec035}
------------------------------------------------------

Participants for whom clinical conditions occurred during pregnancy and childbirth were retained in the study. We then assessed the effect of excluding them on the parameter estimates of the quantiles. We excluded successively maternal conditions, fetal malformations, and neonatal conditions and assessed the fit for the global EFW percentiles. The parameter estimates obtained were indistinguishable.

In order to illustrate variation of the clinically relevant 10th and 90th percentiles for EFW, we compiled the values (without any formal comparison) for 24, 28, 32, and 36 wk of gestation from the present study, the NICHD Fetal Growth Studies \[[@pmed.1002220.ref019]\], a study from D. R. Congo \[[@pmed.1002220.ref030]\], and another study from Norway \[[@pmed.1002220.ref031]\] ([Table 16](#pmed.1002220.t016){ref-type="table"}). Since the other existing multinational study, the Fetal Growth Longitudinal Study of the Intergrowth-21st Project, did not publish EFW but rather AC, which is a major determinant for EFW, we also compiled 10th and 90th percentiles for AC from relevant studies \[[@pmed.1002220.ref018],[@pmed.1002220.ref019],[@pmed.1002220.ref030],[@pmed.1002220.ref032]--[@pmed.1002220.ref034]\] ([Table 17](#pmed.1002220.t017){ref-type="table"}).

10.1371/journal.pmed.1002220.t016

###### The 10th and 90th percentile for estimated fetal weight in relation to other relevant reference values.

![](pmed.1002220.t016){#pmed.1002220.t016g}

  Reference Chart                                      Gestational Week                                     
  ---------------------------------------------------- ------------------ --------- ----------- ----------- -----------
  **10th percentile of EFW (g)**                                                                            
  US, white[^¶^](#t016fn002){ref-type="table-fn"}      289                583       1,045       1,686       2,432
  D. R. Congo[^\#^](#t016fn003){ref-type="table-fn"}   288                576       1,023       1,624       2,310
  **WHO**                                              **286**            **576**   **1,026**   **1,635**   **2,352**
  US, black[^¶^](#t016fn002){ref-type="table-fn"}      286                559       985         1,579       2,264
  Norway[\*](#t016fn004){ref-type="table-fn"}          283                610       1,102       1,730       2,411
  US, Hispanic[^¶^](#t016fn002){ref-type="table-fn"}   279                555       987         1,595       2,298
  US, Asian[^¶^](#t016fn002){ref-type="table-fn"}      275                546       978         1,574       2,262
  **90th percentile of EFW (g)**                                                                            
  Norway[\*](#t016fn004){ref-type="table-fn"}          408                833       1,472       2,304       3,230
  US, white[^¶^](#t016fn002){ref-type="table-fn"}      381                771       1,391       2,276       3,368
  **WHO**                                              **380**            **765**   **1,368**   **2,187**   **3,153**
  US, Hispanic[^¶^](#t016fn002){ref-type="table-fn"}   379                755       1,353       2,209       3,245
  US, black[^¶^](#t016fn002){ref-type="table-fn"}      376                742       1,317       2,135       3,115
  US, Asian[^¶^](#t016fn002){ref-type="table-fn"}      373                737       1,318       2,129       3,111
  D. R. Congo[^\#^](#t016fn003){ref-type="table-fn"}   345                700       1,277       2,083       3,032

Percentiles from the present multinational study (bold), a recent multiethnic national study in the US \[[@pmed.1002220.ref019]\], a study from D. R. Congo \[[@pmed.1002220.ref030]\], and another study from Norway \[[@pmed.1002220.ref031]\] are listed according to descending values at 20 wk, but are not formally compared or ranked.

^¶^Buck Louis et al. \[[@pmed.1002220.ref019]\].

^\#^Landis et al. \[[@pmed.1002220.ref030]\].

\*Johnsen et al. \[[@pmed.1002220.ref031]\].

D. R., Congo, Democratic Republic of the Congo; EFW, estimated fetal weight.

10.1371/journal.pmed.1002220.t017

###### The 10th and 90th percentile for fetal abdominal circumference in relation to relevant reference values.

![](pmed.1002220.t017){#pmed.1002220.t017g}

  Reference Chart                                                  Gestational Week                                 
  ---------------------------------------------------------------- ------------------ --------- --------- --------- ---------
  **10th percentile AC (mm)**                                                                                       
  US, white[^¶^](#t017fn002){ref-type="table-fn"}                  141                185       227       268       306
  **WHO**                                                          **139**            **184**   **225**   **260**   **294**
  Norway[\*](#t017fn003){ref-type="table-fn"}                      139                182       223       262       299
  US, Asian[^¶^](#t017fn002){ref-type="table-fn"}                  139                182       221       260       295
  US, Hispanic[^¶^](#t017fn002){ref-type="table-fn"}               138                181       221       262       299
  Intergrowth-21st Project[^§^](#t017fn004){ref-type="table-fn"}   138                179       219       257       291
  US, black[^¶^](#t017fn002){ref-type="table-fn"}                  137                179       217       267       293
  Thailand[^\#^](#t017fn005){ref-type="table-fn"}                  135                177       217       254       290
  UK[^&^](#t017fn006){ref-type="table-fn"}                         135                175       213       249       283
  **90th percentile AC (mm)**                                                                                       
  Norway[\*](#t017fn003){ref-type="table-fn"}                      165                213       259       303       346
  US, white[^¶^](#t017fn002){ref-type="table-fn"}                  164                212       258       306       353
  US, Hispanic[^¶^](#t017fn002){ref-type="table-fn"}               163                210       255       303       349
  **WHO**                                                          **161**            **210**   **256**   **298**   **340**
  US, Asian[^¶^](#t017fn002){ref-type="table-fn"}                  161                208       252       299       343
  Thailand[^\#^](#t017fn005){ref-type="table-fn"}                  159                208       256       301       339
  US, black[^¶^](#t017fn002){ref-type="table-fn"}                  159                205       249       295       340
  UK[^&^](#t017fn006){ref-type="table-fn"}                         158                204       248       290       330
  Intergrowth-21st Project[^§^](#t017fn004){ref-type="table-fn"}   158                203       248       291       335

Percentiles from the present multinational study (bold), a recent multinational study (Intergrowth-21st Project), a recent multiethnic study in the US, and three studies from Norway, Thailand, and the United Kingdom are listed according to descending values at 20 wk, but are not formally compared or ranked.

^¶^Buck Louis et al. \[[@pmed.1002220.ref019]\].

\*Johnsen et al. \[[@pmed.1002220.ref033]\].

^§^Papageorghiou et al. \[[@pmed.1002220.ref018]\].

^\#^Sunsaneevithayakul et al. \[[@pmed.1002220.ref034]\].

^&^Chitty et al. \[[@pmed.1002220.ref032]\].

AC, abdominal circumference; D. R., Congo, Democratic Republic of the Congo.

Discussion {#sec036}
==========

In this paper we present the WHO fetal growth charts for EFW and common ultrasound biometric measurements intended for international use. They reveal a wide range of variation in human fetal growth across different parts of the world. Significant differences in fetal growth between countries are confirmed by differences in birthweight. Furthermore, the study shows that intrauterine growth is influenced by fetal sex and by maternal age, height, weight, and parity, although these influences explain only partially the differences in growth between countries.

The primary motivation for this study, the fetal component of the WHO Multicentre Growth Reference Study \[[@pmed.1002220.ref011]\], was the need for clinical reference intervals applicable internationally, including for areas of the world where perinatal morbidity and mortality are high, hence the multinational design. Driven by the same motivation, we prioritized ultrasound measurements in common clinical use worldwide, the most prominent being EFW ([Fig 1](#pmed.1002220.g001){ref-type="fig"}; [Table 11](#pmed.1002220.t011){ref-type="table"}). The use of estimated weight in grams is simple and intelligible, which enhances clinical management, facilitates communication within the health care system, and is valuable when counselling patients. In addition to the other common measurements in daily use (BPD, HC, AC, and FL) ([Fig 1](#pmed.1002220.g001){ref-type="fig"}; Tables [6](#pmed.1002220.t006){ref-type="table"}--[9](#pmed.1002220.t009){ref-type="table"}), we established reference intervals for the ratios FL/HC and FL/BPD aimed at facilitating the identification and monitoring of disproportionate fetal head development, e.g., hydrocephaly or microcephaly ([Fig 1](#pmed.1002220.g001){ref-type="fig"}; Tables [12](#pmed.1002220.t012){ref-type="table"} and [13](#pmed.1002220.t013){ref-type="table"}). The diagnosis in pregnancies complicated by such conditions is often hampered by uncertainty about gestational age since head size (BPD and HC) is also commonly used for the dating of the pregnancy. FL/HC and particularly FL/BPD are less dependent on gestational age after 20 wk of gestation ([Fig 1](#pmed.1002220.g001){ref-type="fig"}) and may therefore have diagnostic utility.

A strength of the new growth charts provided by the study (Tables [6](#pmed.1002220.t006){ref-type="table"}--[15](#pmed.1002220.t015){ref-type="table"}) is that they are based on multinational data, i.e., ten countries, and therefore are more likely to be applicable internationally than previously published reference intervals for EFW based on single countries. A recent sizeable study found significant variation in fetal growth between Asian, black, Hispanic, and white ethnic groups, with Asian fetuses being the smallest and white fetuses the largest, justifying ethnic-specific growth charts \[[@pmed.1002220.ref019]\]. However, that study was confined to the US. [Table 16](#pmed.1002220.t016){ref-type="table"} demonstrates the relation between studies for the clinically important 10th and 90th percentiles for EFW. The WHO growth chart for all countries lies in the middle of them. Although the present study was not designed to investigate ethnic differences, a limited record of participants' ethnicity showed a distribution largely according to country ([Table 2](#pmed.1002220.t002){ref-type="table"}). Interestingly, there was a significant difference in the growth of EFW between countries that was not explained by maternal factors ([Fig 3](#pmed.1002220.g003){ref-type="fig"}; [S2 Table](#pmed.1002220.s009){ref-type="supplementary-material"}). While ethnic differences may play a role in this variation, as for the US-based study \[[@pmed.1002220.ref019]\], variation could also be due to differences in diet and cultural and socioeconomic factors commonly associated with particular ethnic groups. These may also have played a role in the US-based study.

Another recently published multinational study by the Intergrowth-21st Project presented biometric growth but not EFW data \[[@pmed.1002220.ref018]\]. We therefore present variation in AC, which is closely linked to EFW and is an important predictor of perinatal outcome \[[@pmed.1002220.ref006]\], for the commonly used cutoffs, the 10th and 90th percentiles ([Table 17](#pmed.1002220.t017){ref-type="table"}). Interestingly, the 10th percentile for the Intergrowth-21st Project results seems to fall below that of the WHO study, even though the Intergrowth-21st Project study was carried out according to a strictly "prescriptive" concept to establish so-called optimal fetal growth (low-risk pregnancies with no environmental and nutritional constraints, and excluding all conditions during pregnancy and childbirth that may be associated with effects on fetal growth). The WHO study had a similar recruitment but retained in the analysis pregnancies with maternal, fetal, and neonatal clinical conditions, based on the principle that reference intervals should reflect as closely as possible the population to which they will be applied. Furthermore, we assessed the effect of removing such pregnancies from the dataset and found no identifiable effect on the percentiles. As seen from [Table 17](#pmed.1002220.t017){ref-type="table"}, it is as if rigorous selection and exclusions have limited effect, and other uncontrolled factors are responsible for the variation between studies and countries. Apart from random error, systematic error due to differences in ultrasound measurement techniques could influence the differences between the studies. However, these studies had well-trained ultrasound operators specifically instructed for the research procedure using internationally accepted techniques, and this should minimize such error.

Another strength of the present WHO study is the use of quantile regression to establish the reference intervals. Quantile regression makes an inference about regression coefficients for the conditional quantiles of a variable without making assumptions about its distribution: there is no need to assume a particular distribution and to estimate its moments. In consequence, it provides a more direct representation of the observed measurements. This is nicely demonstrated in a recent large study establishing population-specific fetal growth charts \[[@pmed.1002220.ref035]\]. The technique is especially useful when the quantiles vary differently with a covariate such as, in the present study, gestational age. In addition, the method is robust against the effect of outliers and can capture important features of the data that might be missed by models that average across the conditional distribution \[[@pmed.1002220.ref025]\].

Quantile regression is particularly useful in studying distribution changes, and shows in the present study that fetal growth in the population is not symmetrical with gestation. Starting with a higher distribution towards the lower percentiles, EFW shifts to an expanded distribution among the higher percentiles and ends with a noticeable asymmetry near term. The Bowley coefficient for asymmetry changed from −0.016 to +0.111 during that period. We are not sure of the nature of the small negative asymmetry in early pregnancy, but speculate that regulatory functions, such as the process of maternal constraint of fetal growth, change through gestation, i.e., fetuses in the higher percentiles may be exposed to greater influences, which vary with maternal characteristics. This corroborates the differential effects of covariates across the percentiles shown in [S1 Fig](#pmed.1002220.s001){ref-type="supplementary-material"}. We believe that studying distribution dynamics may yield more information on the control of fetal growth.

The study confirmed the biologically interesting facts that fetal sex and maternal height, weight, parity, and age significantly influence fetal growth \[[@pmed.1002220.ref031],[@pmed.1002220.ref036],[@pmed.1002220.ref037]\]. Together with the country differences, the ethnic differences shown in the US population \[[@pmed.1002220.ref019]\], and, not least, the substantial variation in birthweight among carefully selected low-risk pregnancies, these findings document a diversity and plasticity in human prenatal growth dynamics that is only partially understood. There is increasing evidence linking fetal development, and proxies of development such as birthweight, to postnatal health and life course risk of disease \[[@pmed.1002220.ref007],[@pmed.1002220.ref009]\]. This issue is prioritized by the UN and WHO at a time when noncommunicable diseases are becoming global epidemics \[[@pmed.1002220.ref010],[@pmed.1002220.ref038]\]. For example, in our study, birthweights in India were significantly lower than in the other countries, and Indian participants also had the lowest fetal growth and were the shortest mothers. It is known that body composition in Indian newborns contains relatively more fat \[[@pmed.1002220.ref039]\], a pattern that passes across generations \[[@pmed.1002220.ref040]\] and that is linked to increased risk of subsequent type 2 diabetes \[[@pmed.1002220.ref041]\]. It seems clear that the understanding of "optimal" fetal growth needs to incorporate more than birthweight.

To have a single fetal growth chart that fits all pregnancies across the world would require that all fetuses had the same genetic background for growth, that this genetic background was reliably expressed in the mother, and that influences such as nutrition, physical activity, stress, toxicants, and other environmental conditions had similar effects on the genotype in all embryos and fetuses. This is very unlikely: recent research has revealed a range of interactions between the developmental environment and genetic and epigenetic processes \[[@pmed.1002220.ref009]\]. Even influences on fetal growth classically thought to be primarily genetic, such as maternal and paternal height, are complicated by environmental factors. Altitude, climate, geography, other environmental conditions, and the challenges of daily life and nutrition vary around the world. Humans adapt across generations to local conditions, and fetal development adds an important adaptive refinement for the next generation. Secular changes in birthweight and child growth patterns have been shown to accompany social changes \[[@pmed.1002220.ref042],[@pmed.1002220.ref043]\]. Fetal growth charts may thus need to be adjusted to fit the diversity of individuals and populations if they are to be of the greatest clinical utility.

While including ten countries in the present WHO study was a strength compared to previous studies, it still has limitations. The ten population samples, including two in South-East Asia and two in Africa, were included to increase generalizability, but they are still a very limited sample of the global human population. Africa alone has a greater genetic diversity than has the rest of the world \[[@pmed.1002220.ref044]\], and anthropometric variation on that continent is substantial. The present study showed population differences within the pooled dataset, and so the extent to which the results can be extrapolated to other populations, which possibly have other growth dynamics, is at present unknown.

A limitation of the study is that ultrasound measurements were accompanied by a corresponding gestational age exposed on the screen, which could have led to undue changes in the management of the pregnancy and pregnancy duration. However, it was common practice among the sonographers and midwives doing the examination not to pay attention to this gestational age because the department was using other reference values than the one on the screen. On the other hand, part of the ethical commitment of the study was actually to let the mother be informed of any abnormality or deviation of importance discovered, so that it could be taken into account for the management of the pregnancy, and to refer the case to the managing clinician. However, the reported referrals were few and were found not to influence the statistics.

Pooling data is not ideal in the presence of variation among populations, and a single overall growth chart will only partially reflect the individual populations included. Figs [4](#pmed.1002220.g004){ref-type="fig"} and [5](#pmed.1002220.g005){ref-type="fig"} show the variation of country-specific percentiles compared with the corresponding overall percentiles of the study and provide an opportunity to assess the magnitude and clinical relevance of the observed variation. Tables [16](#pmed.1002220.t016){ref-type="table"} and [17](#pmed.1002220.t017){ref-type="table"} illustrate a similar pattern when compiling the 10th and 90th percentiles for EFW and AC from various relevant high-quality studies available for clinical use. Although no formal statistical comparison was undertaken, the results of these studies illustrate the distribution that can be found around the world. This gives an impression of a wider spread for the 90th percentile than for the 10th. A similar pattern is found within the WHO study itself: a more obvious diversity between the countries for the 90th percentile than for the 10th percentile ([Fig 3](#pmed.1002220.g003){ref-type="fig"}). As seen from these figures, variation between countries may increase to several hundred grams towards the end of pregnancy, and may cause misclassifications when the overall percentile is used. Secondly, it seems that population variation in growth is more reflected in the 90th percentile than in the lowest percentiles. Thus, it is possible that the 10th, 5th, and 2.5th percentiles of a pooled study are more universally applicable, while the upper percentiles---90th, 95th, and 97.5th---vary more according to population characteristics and accordingly will be more in need of adjustment, i.e., customization, for use at the population level \[[@pmed.1002220.ref037]\].

It follows that whenever the WHO growth charts, or any reference intervals, are applied to a population, their performance should be checked or tested in order to ensure appropriate use. It is possible to adjust them by changing cutoffs (e.g., from 10th to 5th percentile) to fit clinical needs better, and it is possible to customize the percentiles to country, maternal characteristics, and fetal sex to improve diagnostic performance \[[@pmed.1002220.ref045]\]. A further refinement would be to introduce conditioning terms when using repeated ultrasound measurements for monitoring growth \[[@pmed.1002220.ref046],[@pmed.1002220.ref047]\], i.e., narrowing the expected reference interval for an assessment by conditioning it using a previous measurement. WHO is working on these methods to make them generally available with the growth chart.

If such adjustments and refinements do not suffice to make the growth charts fit clinical needs appropriately, then it may be necessary to establish new high-quality reference intervals for a population. For example, the WHO growth charts and many others are based on populations living at altitudes \< 1,500 m. However, millions of people live at higher altitudes, and their physiological adaptations include pregnancy and fetal development. It might be that specific charts will be needed for such populations.

The concept of a "standard," whether international or national, is often used for instruments and methods to make procedures uniform and to reduce random and systematic error, rather than to set a standard for a biological parameter such as height or bodyweight for the population globally. We are inclined to the view that, while the methodology to define reference ranges or charts for fetal growth needs to be standardized, fetal growth itself is a biological parameter expected to reflect adaptive processes and to change with development, time, location, and environmental conditions. Variation in fetal growth within and between populations should therefore not be ignored.

To apply any growth chart sensibly requires insight, critical attitude, and pragmatism. We believe that the present WHO fetal growth charts can be used internationally, particularly where no local data exist. However, once they are in use, it will be prudent to test the performance of the charts in a particular setting in case adjustments, customization, or replacement with population-specific high-quality reference intervals is needed. With the currently varying degrees of resources, health, and needs around the world, health care professionals have the responsibility of fitting and refining the use of the fetal growth charts to best serve the population in their care.
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###### Influence of covariates on estimated fetal weight quantiles.

\(A\) Intercept; (B) fetal sex; (C) parity; (D) maternal age; (E) maternal weight; (F) maternal height; (G) gestational age linear component; (H) gestational age quadratic component; (I) gestational age cubic component. Output of quantile profilers from quantile multivariate regression in the logarithmic scale, presented as the effect of covariates with 95% confidence bands. For binary variables (sex of the fetus and parity), the relative change is between the two categories; for continuous variables, the relative change refers to the increment in EFW resulting from a unit increment of the independent variable (year for maternal age, kilogram for maternal weight, and centimeter for maternal height). Gestational age was included in the model with polynomial terms (linear, quadratic, and cubic).

(DOCX)

###### 

Click here for additional data file.

###### Influence of country on fetal growth expressed as the ultrasound measure biparietal diameter.

Graphs of the 10th, 50th, and 90th percentiles for the ultrasound measure BPD in millimeters for the ten participating countries.

(TIF)

###### 

Click here for additional data file.

###### Influence of country on fetal growth expressed as the ultrasound measure head circumference.

Graphs of the 10th, 50th, and 90th percentiles for the ultrasound measure HC in millimeters for the ten participating countries.

(TIF)

###### 

Click here for additional data file.

###### Influence of country on fetal growth expressed as the ultrasound measure abdominal circumference.

Graphs of the 10th, 50th, and 90th percentiles for the ultrasound measure AC in millimeters for the ten participating countries.

(TIF)

###### 

Click here for additional data file.

###### Influence of country on fetal growth expressed as the ultrasound measure femur length.

Graphs of the 10th, 50th, and 90th percentiles for the ultrasound measure FL in millimeters for the ten participating countries.

(TIF)

###### 

Click here for additional data file.

###### Influence of country on fetal growth expressed as the ultrasound measure humerus length.

Graphs of the 10th, 50th, and 90th percentiles for the ultrasound measure HL in millimeters for the ten participating countries.

(TIF)

###### 

Click here for additional data file.

###### Growth charts for the fetal ultrasound measurements biparietal diameter, head circumference, abdominal circumference, femur length, and humerus length; for estimated fetal weight; and for the ratios femur length/head circumference and femur length/biparietal diameter in one Excel file.

(XLSX)
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Click here for additional data file.

###### Compliance of ultrasound visits with protocol, measured by observed versus expected.

(DOCX)

###### 

Click here for additional data file.

###### Variation of estimated fetal weight quantiles due to country, maternal characteristics (age, height, weight, and parity), and sex of the fetus.

Output from quantile multivariate regression showing Wald chi-square tests for gestational age; country; the interaction of gestational age and country; sex of the fetus; and maternal characteristics.

(DOCX)

###### 

Click here for additional data file.

###### Variation of estimated fetal weight quantiles due to country, maternal characteristics (age, BMI, and parity), and sex of the fetus.

Output from quantile multivariate regression showing Wald chi-square tests for gestational age; country; the interaction of gestational age and country; sex of the fetus; and maternal characteristics.

(DOCX)

###### 

Click here for additional data file.

###### Comparison of country percentiles with overall percentiles.

The 10th, 50th, and 90th percentiles for overall EFW, and the 95% confidence intervals for the difference between each country's percentiles and the overall percentiles at 20, 24, 28, 32, and 36 wk of gestational age. The results should be interpreted with caution (the study was not powered for this analysis; multiplicity of inferences implies that the confidence is much lower than 95%).

(DOCX)

###### 

Click here for additional data file.
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AC

:   abdominal circumference

BMI

:   body mass index

BPD

:   biparietal diameter

D. R. Congo

:   Democratic Republic of the Congo

EFW

:   estimated fetal weight

FL

:   femur length

HC

:   head circumference

HL

:   humerus length

IQR

:   interquartile range

LMP

:   last menstrual period

TI

:   thermal index
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